International
The Morning Science

What science found today

‹
 

Research

U.S. demand for menopause hormone therapy has more than doubled recently

Science News · By Aimee Cunningham ·

U.S. demand for menopause hormone therapy has more than doubled recently

The Brief

  • A study of a U.S. pharmacy database found that use of menopause hormone therapy among women aged 40 to 74 rose from 2023 to 2026.
  • The headline and report describe U.S. demand as having more than doubled recently.
  • The source summary provides no further figures, causes or breakdowns.

Why it matters

Rising use of menopause hormone therapy suggests a major shift in how U.S. women in midlife are being treated, which matters for clinicians, researchers and public health planning.

Who’s affected

  • women aged 40 to 74 in the United States
  • clinicians who prescribe menopause hormone therapy

The use of menopause hormone therapy among women aged 40 to 74 rose from 2023 to 2026, suggests a study of a U.S. pharmacy database.

How do you feel about this?

0 Comments

    U.S. demand for menopause hormone therapy has more than doubled recently – The Morning Science